Aim of the study is to evaluate the expression of CK19, galectin-3, HBME-1, CD56,claudin-1andneutrophilgelatinase-associatedlipocalin(NGAL)inpapillarythyroidcarcinoma(PTC),includingclassic,follicularvariantandmicro-carcinoma.Peritumoralbenignthyroidtissueswereusedasacontrol(C). ImmunohistochemicalstainingwiththeEnVisiondetectionsystemwasperformedon 59formalin-fixed,paraffin-embeddedthyroidtissues,including43PTCand16C. CK19, galectin-3, HBME-1, claudin-1 and NGAL were positive in most PTC, butwerenegativeorshowedfocalweakstaininginC.CD56waspositiveinC,but ab sentinPTC.Forasingleanalyzedtumormarker,thesensitivityoftheabovesix thyroidtumormarkerswas100%,95.3%,86%,79.1%,90.7%,93%,respectively.Thespecificitywas56.25%,100%,100%,100%,100%,100%,respectively. Forthecombinationofthesixtumormarkers,thesensitivity,specificity,positive predictive value, negative predictive value and the diagnostic accuracy were all 100%,withco-expressionofatleastfourindices. InthediagnosisofPTC,combinedapplicationoftheabovetumormarkersisrecommended.ItcanbediagnosedasPTCclearlywhenthyroidlesionsarepositivefor atleastfouroftheabovetumormarkers[CD56(-)],andcanbeexcludedasPTC definitelywhenatleastfourtumormarkersarenegative[CD56(+)].
Introduction
Papillary thyroid carcinoma (PTC) is the most prevalentformofthyroidcancercomprisingapproximately80%ofthyroidepithelialmalignancies [1] . The diagnostic criteria for PTC have been establishedformorethan50years [2] ,pathologicexaminationthroughroutinehematoxylinandeosin(HE) staining was the 'gold standard' diagnosis of PTC [3] .ThediagnosisoftypicalPTCiseasytoachieve through conventional histological evaluation, but for follicular variant or papillary thyroid microcarcinoma,especiallyincaseswithoutobviousinvasion, metastasis or stromal desmoplasia, or unsatisfactory sections, it is usually a great challenge. Taking intoaccountthatover-orunder-diagnosismayhave a great impact on patient management and prognosis, it is necessary to use immunohistochemical stainingwitheffectivetumormarkersasanauxiliary diagnostictooltodiscriminatethesemorphologicallyoverlappingdiseases.
Withhighsensitivityandspecificity,positivestainingpanelofgalectin-3,mesothelialantigenHBME-1 andcytokeratin-19(CK19)havebeenprovedtobe the most promising and most frequently used molecularmarkersinidentifyingpapillarythyroidcancer,includingfollicularvariant [4, 5] .Theywerefirst preferredinmanyhospitalsfortheireaseofuse [4] . CD56, as a neural cell adhesion molecular [6] , was alsoprovedtobefrequentlyexpressedinnormalthyroidtissuesbutabsentinmalignantthyroidtumors, especiallyinPTC [3, 7] .
Claudin-1,anovelmarkerforPTC,isidentifiedas atightjunctioncomponent.Itbelongstotheclaudin family [8] .Severallinesofevidenceatthegene [9, 10] andprotein [7, 11] levelshowedthattheexpression ofclaudin-1waselevatedinPTC,whereas,itwasabsentorweakstainingonthemembraneofnormaland benignthyroidlesions.AnothernewdetectorforPTC isneutrophilgelatinase-associatedlipocalin(NGAL), alsoknownasneu-relatedlipocalin(NRL),oncogene 24p3, uterocalin and lipocalin 2 (LCN2) [12] . It is involvedincancero-genesisandcancerprogressionby increasingironuptakefromtheextracellularspaceto inner cells which is essential for neoplastic cell multiplication [13] .Barresiet al. [13, 14] reportedthat NGAL expression appeared to be significantly more frequent in the malignant thyroid tumors than in benignones,thelaterincludingfollicularadenomas, Hürthlecelladenomasandatypicaladenomas.What ismore,noNGALstainingwasfoundinthenormal thyroidgland,nodularcolloidgoitersorinHashimoto's thyroiditis. Hence, NGAL and claudin-1 might constituteaneffectiveauxiliarydiagnosisindexinthe discriminationofthyroidcarcinoma.
Hence, immunohistochemical staining with the above six thyroid tumor markers was designed to compare their expression in PTC (including classic, follicular, and micro variant) with peritumoral benignthyroidtissues(C),andtoevaluatetheirvalue inthediagnosisofPTCaloneandincombination.
Material and methods

Materials
All materials for this experiment were collected from the Pathology Department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology. According to diagnosticcriteriabasedontheWorldHealthOrganizationHistologicalClassification(2003),59speci-mensofsurgicalremoved,formalin-fixedandparaffin-embedded thyroid lesions during the period of January2011toMarch2013wereselected,including43casesofPTCand16peritumoralbenignthy-roid tissues (C). Regarding to the histological subtypeofPTC,15caseswereclassicvariant(PTC-C), 21follicularvariants(PTC-FV)and7papillarythy-roidmicrocarcinoma(PTMC).Threemalesand40fe-maleswereincluded,rangingfrom16to63yearsold (mean:39.58±11.052years).
Immunohistochemistry
ImmunohistochemicalstainingwiththeEnVision detection system was performed on consecutive sections (4 µm thick) from each archival tissue block. Primaryantibodies,sources,anddilutionsarelistedin TableI.Accordingtothemanufacturer'sinstructions, allsectionsweredeparaffinizedwithxylene,andrehydratedthroughaseriesofdescendinggradedalcohols. Antigenretrievalwasperformedin1mMEDTApH 8.0(CK19,galectin-3,CD56,claudin-1)orincitrate bufferpH6.0(NGAL)inapressurecookerfor1.5min-utesat120°C.Sectionsdidnotundergotheantigen retrieval program with HBME-1. Endogenous peroxidase activity was blocked by using 3% H 2 O 2 for 20min.Theywerethenincubatedwithprimaryantibodyfor1houratroomtemperature,followedby a peroxidase-conjugated polymer (Dako REAL EnVision/HRP,Rabbit/Mouse(ENV)reagentofthekit k5007,Denmark)for30min.Torevealtheimmune staining, the sections were incubated with Dako REAL DAB+ Chromogen for 5 min (Dako k5007, Denmark), followed by counterstaining with hematoxylin,thendehydrationandmounting.Slideswere examined using a BX50 optical microscope (Olympus,Japan)withaSPOT-IIdigitalimagingsoftware (DIAGNOSTICInstruments,inc.USA).Normalhumanskinwasusedasapositivecontrolforclaudin-1, humancolontissueforlipocalin2(NGAL),gastroin- 
Evaluation of immunohistochemical staining
Theresultsofimmunohistochemicalstainingwere assessed by two pathological professors and a consensus regarding controversial cases was reached at a multiheaded microscope. The cells were regarded as positive for these proteins when immunoreactivity was clearly observed in their nuclei, membrane and/orcytoplasm.Stainingofthefollicularcolloidin the absence of staining of the follicular epithelium was considered nonspecific and negative. We used asemi-quantitativescoringmethodforeachimmunohistochemicalmarkerwiththecut-offvaluesbased ondatapublishedpreviously [4, 11, [14] [15] [16] [17] andthe clinicalexperienceofthepathologistsinvolved(NapingLiandXiWang).Thepercentageofpositivecells for each section was counted under 5 high power fields,andthemeanvalueofeachcasewasscoredas follows:0,stainingin<10%ofthecells;1,staining in10-25%ofthecells;2,stainingin26-50%ofthe cells; 3, staining in > 50% of the cells. A score of 0 was considered as negative, and scores of 1 to 3 wereconsideredaspositive.
All statistics were analyzed using SPSS version 18.0.Fisher'sexactprobabilitytestwasusedforsignificanceanalysis(p<0.05).Inaddition,thesensitivity, specificity, positive predictive value, negative predictivevalueandthediagnosticaccuracyforeach indexwereassessedasfollows: sensitivity = true positive/true positive + false negative;specificity=truenegative/truenegative+ falsepositive;positivepredictivevalue=trueposi-tive/truepositive+falsepositive;negativepredictive value=truenegative/truenegative+falsenegative; thediagnosticaccuracy=truepositive+trueneg-ative/truepositive+falsenegative+truenegative +falsepositive.
Results
Immunolocalization of the above six thyroid tumor markers in follicular epithelium
AsshowninFig.1,CK19,galectin-3andNGAL mainlyexpressedinthecytoplasm;atthesametime, Galectin-3andNGALalsoshowedoccasionalnucle-ar expression (Fig. 1B-D top) . Claudin-1 expressed mainly on the membrane surface, accompanied by weakcytoplasmpositiveexpression (Fig.1E) .CD56 often showed strong and complete membrane expression in benign thyroid follicular cells, especially the benign cells adjacent to tumor regions (Fig. 1F lowerleftside).TheexpressionofHBME-1ismain-ly on the membrane, which is at the luminal side, papillaryorthelateralmembranoussurface,withor withoutthecytoplasmandthecontentofglandular cavitystainingpositive (Fig.1Gupperrightside) .
The expression of the above six tumor markers in PTC and benign thyroid tissues alone and in combination CK19 was positive in all cases of PTC, among which39cases(88.37%)showedmoderateorstrong and diffuse expression (Fig. 1B top) , while in 16 C tissues only 7 cases were moderate to weakly positive.Galectin-3waspositivein41/43casesofPTC (95.3%),amongwhich24casesshowedaweakbut diffusestainingpattern (Fig.1Ctop) ,whereasin16C, galectin-3 was completely negative (Fig. 1C bottom) . With high sensitivity (95.3%) and specificity (100%), galectin-3 was an appropriate indicator to differentiatePTCfrombenignthyroidlesions.
Besides CK19 and galectin-3, NGAL also frequently(33/43)showedmoderateorstrongexpressioninPTCtissues (Fig.1D) ,only3PTCbeingneg-ativeforNGAL,whileall16Ccaseswerenegative forNGAL (Fig.1Dinset) .Inaddition,thecontentof follicularcavitiesinCalsoshowedoccasionalNGAL protein expression, while in tumors with follicular structure(suchasPTC-FV),itwasabsent.Inaword, allthesefeaturesofNGALmaycontributetodifferentiatingmalignantthyroidtumorsfrombenignlesions. Furthermore, 90.7% of PTC was positive for claudin-1,amongwhich74.42%(32/43)wasmoderatetostronglypositive (Fig.1E) .In16C,claudin-1 wasabsentorshowedaweakcytoplasmstainingpatternwhichwasalsoconsideredasnegative (Fig.1E  inset) .Hence,claudin-1wasalsoprovedtobeanovel effectiveauxiliarydiagnosticindicatorfortheevaluationofPTC.
Inourresearch,CD56oftenshowedmoderateto strong expression in all C tissues (Fig. 1F lower left side) (specificity 100%), whereas in PTC, 79.1% (34/43)ofcaseswerecompletelynegativeorshowed focalweakstainingpattern (Fig.1Fupperrightside) . Inshort,CD56wasagoodnegativeindicatorforthe diagnosisofPTC.HBME-1wasdiffuselypositivein 86% (37/43) of cases of PTC (Fig. 1G upper right  side) .Incontrast,16Ctissueswerecompletelynega-tiveforHBME-1 (Fig.1Glowerleftside) .Hence,one cansee,withhighsensitivityandspecificity,HBME-1 isalsoagoodmarkertodifferentiatePTCfromC.
The expression of CK19, galectin-3, HBME-1, CD56,claudin-1andNGALinPTCandCisshown inTableII.Fisher'sexactprobabilitytestshowedthat thedifferencesfortheexpressionoftheabovesixthyroidtumormarkersbetweenPTCandCwereallstatisticallysignificant(allp<0.001).Inaddition,no statistically significant difference for the expression 
n -the number of cases, PTC -papillary thyroid carcinoma, PTC-C -papillary thyroid carcinoma-classic, PTC-FV -papillary thyroid carcinoma-follicular variant, MPTC -papillary thyroid micro-carcinoma
Discussion
Although CK19, galectin-3, HBME-1, CD56, claudin-1 and NGAL have all been shown to have high sensitivity and specificity in discrimination of PTCfrombenignthyroidlesions,theresultsvaried amongstudies.Inaddition,inclinicalwork-up,how to best use these tumor markers has not been addressedfully.
In our research, CK19, the most sensitive markerforPTC,isconsistentlyover-expressedinallPTC (100%). Focal or scattered CK19 staining may be foundinbenignlesions(includingfollicularadenoma andnodulargoiter),butonlydiffuselyandstrongly CK19positivestaininghasdiagnosticvalueforPTC [5, 18] .Inaccordancewithpreviousreports [5, 18] , the specificity of CK19 is 56.25% (9/16), which is the lowest in this experiment. The majority of the immunoreactivityoccurredinareasofdegeneration, indicating the reactive nature of CK19 positivity [19] .Atthesametime,withhighnegativepredictive value(100%),wecanexplicitlyexcludethediagnosis ofPTCinthyroidlesionswithoutCK19expression.
Galectin-3isaβ-galactoside-bindinganimallectin which participates in cell-cell and cell-matrix adhesion, cell growth and cell cycle regulation, neoplastic transformation, metastasis, cellular damage reparationandapoptosis [17] .Ithasbeen noted tobe expressedinPTCandtransformedthyroidcelllines but not in normal thyroid cells [20, 21] . HBME-1 isamonoclonalantibodydevelopedagainstthemicro-villous surface of mesothelial cells and subsequently applied in the diagnosis of malignant thyroidtumors [22] .Galectin-3andHBME1havebeen demonstrated in follicular carcinomas and less frequentlyinadenomas.Inourresearch,theyhadthe highest specificity and positive predictive value (all were 100%), but several studies have shown galectin-3 expression in benign conditions and FAs, as wellasstaininginflammatorycellsandreactivenormalepithelium [5] ,limitingtheusefulnessofgalectin-3indiscriminatingbenigndiseasefromPTC.AlthoughHBME-1wasnotsensitiveenough(86%),it wasspecificforPTC.ThyroidlesionswithHBME-1 strongdiffusepositivitycanbedefinedasPTCclearly. In addition, for galectin-3 and HBME-1 expressionatypicalcases,combinedapplicationwithother effectivetumormarkerswasnecessary.
ItisreportedthattheexpressionofCD56isclose-lyrelatedtothedifferentiationofthyroidepithelium [23] .Consistentwithothers'research [3, 24] ,wedetectedmoderateorstrongexpressionofCD56inallC, whileitwasnegativein79.1%(34/43)ofPTCcases.LackofCD56expressioninfollicularcell-derived papillarycarcinomaswasextremelyhelpfulindifferentiatingPTC [3] ,particularlythefollicularvariant and microcarcinoma from other follicular-derived neoplasms/lesions. Although it was not sensitive enough (only 79.1%), the negative predictive value was100%.ItcanbediagnosedasPTCdefinitelyin thyroidlesionswithoutCD56expression.ItisspeculatedthatCD56expressionwasinvolvedintheac-tivationofepithelialmesenchymaltransition(EMT) (which contributed to the development of more migratory and invasive cancers), and modulation of genesregulatingmetastasisasthevascularendothelialgrowthfactor(VEGF) [25, 26] .Thiscouldexplain the maintained elevated CD56 expression in some PTCcaseswhichmayacquirelateramoreaggressive andmetastaticphenotype [7] .However,thisalsoincreased the false positive rate, thereby limiting the usefulnessofCD56inthediagnosisofPTCalone.
Claudin-1 was the first member of the claudin family to be identified as a tight junction component [8] .IntheresearchofNémethet al. [11] they demonstrated a strong expression of claudin-1 proteininPTCandtheirregionallymphnodemetastasescontrastedwithweakornoexpressioninfollicular thyroidcancers,follicularadenomas,andintheperitumoralnon-malignantthyroidtissue.Itconfirmed that high claudin-1 expression was related to papillarymorphology,includingthefollicularvariant [11] . Onepossiblemechanismofclaudin-1over-expression in the development of PTC is that up-regulation or abnormal expression of some claudins may facilitate tumorformationbydirectlyalteringthefunctionof TJthroughtheMEK-2activation [27] oraffectcell signallingpathwaysbybindingdomainstoZO-1 [28, 29] , which interacts with several signalling proteins relatedtotheneoplasticprocess,suchasRassubstrate AF-6,G-proteinandconnexin.Incontrastwithpreviousreports [7, 11] ,weoccasionallyfoundclaudin-1 expression on the cytoplasm of atypical follicular cellsinC.Thismaybeexplainedbyclaudin-1being a four-time trans-membrane protein [30] , so there should be claudin-1 staining on the cytoplasm near themembrane.Butifsectionsweremadeunsatisfactorilyorclaudin-1islocatedonboththemembrane andcytoplasm,itmayinterferewithourclearanalysis of claudin-1 immune location, thereby affecting the usefulnessofclaudin-1inthediagnosisofPTC.
Neutrophil gelatinase-associated lipocalin, a proteinsecretedbyhumanthyroidcarcinomas,isinduced by the same factors that promote the development ofcancer [31] .Nuclearfactor-κBcontributestothy-roidtumorcellsurvivalbycontrollingironuptakevia NGAL [32] .Inaddition,NGALmayinducecancer progression through the positive modulation of matrixmetallo-proteinase-9(MMP-9) [33] ,andincrease theinvasivenessofcancercellsbydecreasingE-cadherin-mediatedcell-celladhesionthroughaniron-dependent mechanism [34] . In line with research by Barresiet al. [13, 14] ,NGALexpressionappearedto bespecific(100%)forthyroidcarcinomaandrepresentedasensitivemethod(93%)inPTCincomparisontoC.Inaddition,thecontentoffollicularcavities inCalsoshowedoccasionalNGALexpression,while intumorswithfollicularstructure(suchasPTC-FV), it was negative. In conclusion, all these features of NGAL can contribute to differentiating malignant tumorsfrombenignlesions.Itwasnoteworthythat all immunohistochemical procedures were repeated severaltimeswithanendogenousbiotin-freesystem, butthecontentsofbenignthyroidfollicularcavities still occasionally showed NGAL protein expression, whichwaslikelytocauseNGALfalsepositivityinC. Hence,forNGALstaininginatypicalcases,thediagnosisofPTCshouldbecautious,andcombinedapplicationwithotherspecifictumormarkersisessential.
Althoughtheabovesixindicatorsareuseful,they shouldbeusedcautiouslyasnonethemwere100% reliable.IntheresearchofAbdElAttiet al. [7] ,thyroid lesions showed that the claudin-1(+)/CD56(-) panel can be diagnosed as PTC definitely, whereas cases with the claudin-1(+)/CD56(+) panel still cannotbeidentifiedasbenignormalignantclearly. Combinedapplicationoftheabovesixindicatorscan solve this problem. In our research, all PTC had at leastfouroftheabovetumormarkers'co-expression, whereas benign thyroid tissues were negative for at leastfourtumormarkers.Forthecombinationofthe six above tumor markers, the sensitivity, specificity, positive predictive value, negative predictive value and the diagnostic accuracy were all 100% with at leastfourtumormarkers'co-expression.
